GLA and Fabry disease: Seven kidney transplant recipients (2.6%) reported a GLA mutation: two patients had a classic phenotype with Fabry nephropathy and started the enzyme replacement therapy, while in four patients we found a pathogenic mutation with no clear evidences of FD-related clinical manifestations.